Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Issued (2023 - 2025)

Historic Shares Issued for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $32.6 million.

  • Camp4 Therapeutics' Shares Issued rose 10493870.97% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.9 million, marking a year-over-year increase of 5275533.98%. This contributed to the annual value of $76.4 million for FY2024, which is 4117189.19% up from last year.
  • Per Camp4 Therapeutics' latest filing, its Shares Issued stood at $32.6 million for Q3 2025, which was up 10493870.97% from $76.3 million recorded in Q4 2024.
  • Camp4 Therapeutics' Shares Issued's 5-year high stood at $76.3 million during Q4 2024, with a 5-year trough of $2000.0 in Q1 2024.
  • Its 3-year average for Shares Issued is $21.8 million, with a median of $173000.0 in 2023.
  • In the last 5 years, Camp4 Therapeutics' Shares Issued skyrocketed by 4401560.69% in 2024 and then surged by 10493870.97% in 2025.
  • Camp4 Therapeutics' Shares Issued (Quarter) stood at $173000.0 in 2023, then soared by 44015.61% to $76.3 million in 2024, then tumbled by 57.33% to $32.6 million in 2025.
  • Its Shares Issued stands at $32.6 million for Q3 2025, versus $76.3 million for Q4 2024 and $31000.0 for Q3 2024.